Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Stakeholder Insight: Prostate Cancer Treatment and Commercial Issues' returned 2 results - Page 1 of 1  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Antibody drug conjugates for cancer treatment: Clinical Tria... Anticancer Therapeutics   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Dealmaking and Industry Outlook: Targeted Cancer Therapies   Decision Resources, Inc., Dec 2009, Pages: 38 that are developing targeted therapies? - Decision Resources analysts weighed in with their insights on the current status and future directions of targeted cancer therapies. What is limiting the commercial potential Companion Biomarkers in Drug Development   TriMark Publications, April 2009, Pages: 320 .7.5.6 SELDI and Treatment Monitoring 112 3.7.5.7 Limitations of Mass Spectroscopy 112 3.7.6 Partnerships for Developing Proteomic Biomarkers 114 3.7.7 Proteomics in Developing a New Cancer Marker 114 3 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network